Table 1.
Conjugates | ADH linkers per protein | Recovery (%) | Average size (kDa) |
Vaccine Formulation | ||
---|---|---|---|---|---|---|
Vi | ΔVP8* | Vi (μg) | ΔVP8* (μg) | |||
Vi-ΔVP8*-P[4] | 4 | 35 | 10 | 2665 | 5 | 1.0 |
Vi-ΔVP8*-P[6] | 6 | 33 | 11 | 2583 | 5 | 1.1 |
Vi-ΔVP8*-P[8] | 5 | 44 | 15 | 2773 | 5 | 1.5 |
Multivalent formulation | – | – | – | – | 15 | 3.6 |
1Recovery of each conjugate obtained was calculated on the basis of Vi concentration and protein concentration.
2Vi concentration was based on Hestrin assay.
3ΔVP8* protein concentration was based on Bradford assay.
4Multivalent formulation is the mixture of Vi-ΔVP8*-P[4], P[6], and P[8].